Pereira Olga M, Cruz Ortiz Soan G, Llorens Amaury, Rosa Edgardo Rivera
Department of Obstetrics and Gynecology, San Juan City Hospital, San Juan, Puerto Rico.
Bol Asoc Med P R. 2013;105(3):25-8.
To describe the pregnancy and neonatal outcomes of women receiving 17alpha-hydroxyprogesterone to prevent subsequent preterm birth in our institution.
Forty-two patient received treatment by VITA healthcare and their charts were reviewed for results and outcomes.
An increase in average gestational age at the time of delivery was noticed as well as an increase in weeks gained compared to previous preterm birth.
More than 75% of the patients prolonged their pregnancy with the use of 17alpha-hydroxyprogesterone. Continuation of the study and stratifying patients will help in identifying other risk factors and establishing criteria for improved prevention of preterm birth and prognosis.
描述在我们机构接受17α-羟孕酮预防后续早产的女性的妊娠和新生儿结局。
42例患者接受了VITA医疗保健公司的治疗，并对其病历进行了结果和结局审查。
注意到分娩时平均孕周增加，与之前的早产相比，孕周增加数也有所增加。
超过75%的患者使用17α-羟孕酮后延长了妊娠期。继续开展该研究并对患者进行分层将有助于识别其他风险因素，并确立改善早产预防和预后的标准。
